Tag: Statins
Adherence and Intensity of Lipid-Lowering Tx Influence CV Risk
Lowest risk seen for adherent patients receiving high-intensity statin and/or ezetimibe regimen
AHA Scientific Statement: Low Risk of Side Effects for Statins
Risk for statin-induced serious muscle injury <0.1 percent, newly diagnosed diabetes ~0.2 percent
Onset of Musculoskeletal Adverse Events Varies Between Statins
Significantly faster onset with atorvastatin, rosuvastatin versus simvastatin during monotherapy
Nonadherence, Discontinuation of Statins High in 1st Year of Rx
Among older adults prescribed statins, diabetes, anxiety linked to nonadherence, discontinuation
Link Between Statins, Non-CVD Outcomes Lacks Evidence
Review of observational studies, randomized trials shows absence of convincing evidence
Statins Improve Long-Term Survival After AAA Repair
Findings in those taking statins before abdominal aortic aneurysm repair or initiating before discharge
Widespread Statin Use Not Recommended in Old, Very Old
No benefit in healthy elderly patients; protective effect limited to those with type 2 DM aged 75 to 84
PCP Statin Prescribing Up With Automated Patient Dashboard
Modest increase in prescribing with automated dashboard using active choice framing for PCPs
African-Americans Less Likely to Get Recommended Statin Therapy
Socioeconomic, demographic, belief-related and clinician differences are contributing factors
Women Less Likely to Fill Post-MI Statin Prescription
56 percent of men, 47 percent of women filled high-intensity statin after myocardial infarction
